Most VC conversations focus on the GP-founder relationship. But the LP-GP relationship is equally consequential — and equally misunderstood. Here is what limited partners are actually evaluating when they commit capital to a fund.
There is a persistent asymmetry in how the venture capital world is discussed. The GP-founder relationship receives enormous attention — how to pitch, how to negotiate terms, how to manage board dynamics. The LP-GP relationship receives far less, despite being equally consequential for how capital flows through the ecosystem and which companies ultimately get built.
Having spent years on both sides of this relationship — allocating capital as part of a portfolio and helping founders navigate fundraises — I want to offer something that is rarely made explicit: what limited partners are actually evaluating when they decide to commit to a fund. Not what GPs assume we care about, but what we are genuinely looking for.
Every GP pitching a fund shows returns. The returns are the starting point of the conversation, not the destination. What LPs are actually trying to determine is whether those returns are repeatable, attributable to the GP's specific capabilities, and likely to persist in the current environment.
A fund that returned 5x in 2015 by investing early in SaaS infrastructure companies was making excellent decisions in context. Whether that same team can generate equivalent returns in a market that is more crowded, more competitive, and operating with higher interest rates and compressed multiples is a separate question — and it is the question that matters.
We are not buying history. We are buying judgment about the future. The historical returns are evidence about the quality of that judgment, but only when we understand the conditions that produced them and whether those conditions still obtain.
Many fund pitches are built around a single partner — the most recognisable name, the best-known deal, the person who sits on the most boards. LPs should be, and increasingly are, sceptical of these star-based pitches.
A fund's ability to generate returns over ten years depends on the actual team that will be doing the work throughout the fund's life. It depends on how decisions are made when partners disagree. It depends on what happens when a key person leaves — because in any ten-year fund, someone always leaves. It depends on whether the junior partners are being genuinely developed or simply provided as infrastructure for the senior partner's deal flow.
We spend a significant amount of diligence time with junior and mid-level partners precisely because of this. If the senior partner is compelling but the next generation of the team is uncertain, that fund is taking a key-man risk that is underpriced in the management fee and carry structure.
How a GP runs their fund is a strong signal of how they will handle your capital. LPs look at seemingly mundane operational indicators: Are quarterly reports delivered on time? Are valuations marked to market consistently, or do they drift positive and correct abruptly? When there is a portfolio company problem, do we hear about it from the GP before we have to ask?
These patterns matter because they reveal something about the GP's orientation toward transparency and accountability. Investors who are rigorous about reporting when things are going well tend to be rigorous when things go badly. Investors who manage information carefully during the good years often manage it defensively during the bad ones.
Operational quality also predicts how well a GP will perform at the portfolio company level. An investor who cannot execute a quarterly report on time is unlikely to be genuinely helpful to a founder navigating the operational complexity of a growing company.
The standard fund commitment is a ten-year engagement. Within that period, there will be capital calls that arrive at inconvenient moments, portfolio companies that perform disappointingly, market conditions that make the strategy look ill-timed, and decisions that require LP consent or LPAC review. The quality of that relationship — the communication, the responsiveness, the honesty — matters enormously.
LPs who treat fund selection as a transaction — comparing projected IRR across a spreadsheet and selecting the highest number — consistently make poor decisions. The fund with the highest projected return is also often the fund with the least margin for error, the most aggressive deployment strategy, and the least willing-to-be-honest GP relationship.
The LPs who consistently access the best funds are the ones who have invested in relationships over time — providing genuine value to GPs through their networks, their strategic perspective, or their willingness to be thoughtful and helpful LPACs. The best funds do not need your capital. They are choosing their investors carefully. Being chosen requires being genuinely useful.
For balance: there are things that GPs consistently do in LP fundraises that are deeply unhelpful and that reveal misunderstandings about what LPs actually need.
Projecting returns with false precision is near the top of the list. Showing a model that predicts a 4.2x net return based on assumptions about entry multiples, exit timing, and market conditions that have not existed since 2021 does not instil confidence. It signals that the GP either does not understand how LP diligence works, or believes that confident presentation can substitute for honest analysis.
Cherry-picking attribution is equally damaging. Claiming credit for the returns generated by investments made by a predecessor firm, a co-investor, or a partner who has since left creates a track record that collapses under scrutiny. We do the work. We check the attribution. GPs who misrepresent it lose not just the commitment, but any future opportunity in that LP's network.
The LP-GP relationship, when it works well, is one of the most powerful mechanisms for allocating capital toward the future. LPs who do their work carefully, who bring genuine judgment to fund selection, and who hold GPs accountable for both returns and behaviour, improve the quality of the entire ecosystem.
Those that do not — that allocate based on brand, relationships, or simplified return metrics — inadvertently subsidise mediocre fund management and deprive the best GPs of the patient, engaged capital they need to back unconventional ideas in inconvenient places.
The most important thing I can say to any first-time LP is this: treat this as a long-term craft, not a decision to make once. The venture ecosystem rewards accumulated judgment, sustained relationships, and genuine intellectual engagement. If you bring those things, the best GPs will want you in their funds — and that, more than any projected return, is the foundation of strong long-term performance.